BENYUNES; Mark C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BENYUNES; Mark C..The latest application filed is for "adjuvant treatment of her2-positive breast cancer".

Company Profile

4.3.12

BENYUNES; Mark C. - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adjuvant Treatment Of Her2-positive Breast Cancer App 20210330789 - BENYUNES; Mark C. ; et al.	2021-10-28
Adjuvant treatment of HER2-positive breast cancer Grant 11,077,189 - Benyunes , et al. August 3, 2	2021-08-03
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20210015919 - Benyunes; Mark C. ; et al.	2021-01-21
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20200376120 - Benyunes; Mark C. ; et al.	2020-12-03
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20200206348 - Benyunes; Mark C. ; et al.	2020-07-02
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20190117769 - Benyunes; Mark C. ; et al.	2019-04-25
Adjuvant Treatment Of Her2-positive Breast Cancer App 20180250397 - BENYUNES; Mark C. ; et al.	2018-09-06
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20160175438 - Alavattam; Sreedhara ; et al.	2016-06-23
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab App 20130095172 - Alavattam; Sreedhara ; et al.	2013-04-18
Therapy Of Autoimmune Disease In A Patient With An Inadequate Response To A Tnf-alpha Inhibitor App 20110300136 - BENYUNES; MARK C.	2011-12-08
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-.alpha. inhibitor Grant 7,976,838 - Benyunes July 12, 2	2011-07-12
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-.alpha. inhibitor Grant 7,708,994 - Benyunes May 4, 2	2010-05-04
Therapy Of Autoimmune Disease In A Patient With An Inadequate Response To A Tnf-alpha Inhibitor App 20080213280 - BENYUNES; MARK C.	2008-09-04
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor App 20060240008 - Benyunes; Mark C.	2006-10-26
Therapy of autoimmune disease in a patient with an inadequate response to TNF-alpha inhibitor App 20040202658 - Benyunes, Mark C.	2004-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.